摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

17-methyl-4,5α-epoxy-6-one-3-methoxy-8-[thioacetic acid]morphinan | 1418280-96-2

中文名称
——
中文别名
——
英文名称
17-methyl-4,5α-epoxy-6-one-3-methoxy-8-[thioacetic acid]morphinan
英文别名
8-thioacetic acid hydrocodone;2-[[(4R,4aR,7aR,12bS)-9-methoxy-3-methyl-7-oxo-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-5-yl]sulfanyl]acetic acid
17-methyl-4,5α-epoxy-6-one-3-methoxy-8-[thioacetic acid]morphinan化学式
CAS
1418280-96-2
化学式
C20H23NO5S
mdl
——
分子量
389.472
InChiKey
BMMSKJQLOQHZMI-PSTOXSJPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    101
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Reduced Antinociception of Opioids in Rats and Mice by Vaccination with Immunogens Containing Oxycodone and Hydrocodone Haptens
    摘要:
    Prescription opioids abuse and associated deaths are an emerging concern in the USA. Vaccination against prescription opioids may provide an alternative to pharmacotherapy. An oxycodone hapten containing a tetraglycine linker at the C6 position (60XY(Gly)(4)OH) conjugated to keyhole limpet hemocyanin (KLH) has shown early proof-of-efficacy in rodents as a candidate immunogen (60XY(Gly)(4)-KLH) for the treatment of oxycodone abuse. In this study, oxycodone-based and hydrocodone-based haptens were conjugated to KLH to generate immunogens that would recognize both oxycodone and hydrocodone. Vaccination with 60XY(Gly)(4)-KLH increased drug binding in serum, reduced drug distribution to brain, and blunted analgesia for both oxycodone and hydrocodone. An analogous C6-linked hydrocodone vaccine blocked hydrocodone effects but less so than 60XY(Gly)(4)-KLH. C8-Linked hydrocodone immunogens had only limited efficacy. Amide conjugation showed higher haptenation ratios and greater efficacy than thioether conjugation to maleimide activated KLH (mKLH). The 60XY(Gly)(4)-KLH vaccine may be used for treatment of prescription opioid abuse.
    DOI:
    10.1021/jm3013745
  • 作为产物:
    描述:
    巯基乙酸可待因酮四氢呋喃 为溶剂, 反应 20.0h, 以87%的产率得到17-methyl-4,5α-epoxy-6-one-3-methoxy-8-[thioacetic acid]morphinan
    参考文献:
    名称:
    COMPOSITIONS AND METHODS OF TREATING OPIOID ADDICTION
    摘要:
    本发明涉及用于治疗阿片类药物成瘾的结合物和疫苗组合物,以及这些结合物和组合物的使用方法。
    公开号:
    US20140093525A1
点击查看最新优质反应信息

文献信息

  • Reduced Antinociception of Opioids in Rats and Mice by Vaccination with Immunogens Containing Oxycodone and Hydrocodone Haptens
    作者:Marco Pravetoni、Morgan Le Naour、Ashli M. Tucker、Theresa M. Harmon、Tara M. Hawley、Philip S. Portoghese、Paul R. Pentel
    DOI:10.1021/jm3013745
    日期:2013.2.14
    Prescription opioids abuse and associated deaths are an emerging concern in the USA. Vaccination against prescription opioids may provide an alternative to pharmacotherapy. An oxycodone hapten containing a tetraglycine linker at the C6 position (60XY(Gly)(4)OH) conjugated to keyhole limpet hemocyanin (KLH) has shown early proof-of-efficacy in rodents as a candidate immunogen (60XY(Gly)(4)-KLH) for the treatment of oxycodone abuse. In this study, oxycodone-based and hydrocodone-based haptens were conjugated to KLH to generate immunogens that would recognize both oxycodone and hydrocodone. Vaccination with 60XY(Gly)(4)-KLH increased drug binding in serum, reduced drug distribution to brain, and blunted analgesia for both oxycodone and hydrocodone. An analogous C6-linked hydrocodone vaccine blocked hydrocodone effects but less so than 60XY(Gly)(4)-KLH. C8-Linked hydrocodone immunogens had only limited efficacy. Amide conjugation showed higher haptenation ratios and greater efficacy than thioether conjugation to maleimide activated KLH (mKLH). The 60XY(Gly)(4)-KLH vaccine may be used for treatment of prescription opioid abuse.
  • COMPOSITIONS AND METHODS OF TREATING OPIOID ADDICTION
    申请人:Minneapolis Medical Research Foundation
    公开号:US20140093525A1
    公开(公告)日:2014-04-03
    The present invention relates to conjugates and vaccine compositions for treatment of opioid addiction, and methods of use of these conjugates and compositions.
    本发明涉及用于治疗阿片类药物成瘾的结合物和疫苗组合物,以及这些结合物和组合物的使用方法。
查看更多